Tag: OReO/ENGOT Ov-38

PARP inhibitor rechallenge improves PFS in ovarian cancer

Presented By

Dr Eric Pujade-Lauraine, Université Paris Descartes, France

Trial

Phase 3, OReO/ENGOT Ov-38

Conference

ESMO 2021